# Larkspur Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/larkspur-biosciences

- Industry: Biotechnology
- Headquarters: Watertown, US
- Website: www.larkspur.bio
- Total disclosed funding: $18M
- Latest round: Series A (May 23, 2023)
- Investors on record: 6

## About

Based in the US, and founded in 2020, Larkspur Biosciences operates as a biotechnology business that is working to develop the next generation of precision immunotherapies to combat cancer. In May 2023, Larkspur Biosciences raised USD 17.55 million in series A funding co-led by new investors 3E Bioventures Capital, Polaris Partners and Takeda Ventures, with participation from other new investors Cornell University Endowment, Creacion Ventures and MED-FINE Capital.

Larkspur Biosciences specializes in the development of immunotherapies that aid in the treatment of cancer. The company provides immunotherapy solutions that are tailored to specific patient populations based on molecular definitions, and they target the critical interface between the tumor and the immune system. This method enables patients, including those with colorectal cancer (CRC) and other diseases, to mount a powerful and long-lasting immune response.

The company plans to use the May 2023 funding to support R&D, focus on IND-enabling studies for its lead program and the ongoing preclinical studies for its program targeting Pin1 to develop therapies for the treatment of colorectal cancer.

## Funding rounds

- Series A, May 23, 2023, $18M — Polaris Partners, Cornell University Endowment, Takeda Ventures, 3E Bioventures Capital, MED-FINE Capital, Creacion Ventures

## Investors

- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series A
- Cornell University Endowment — Series A
- Takeda Ventures (https://capitalatlas.ai/funds/takeda-ventures) — Series A
- 3E Bioventures Capital (https://capitalatlas.ai/funds/3e-bioventures-capital) — Series A
- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Series A
- Creacion Ventures (https://capitalatlas.ai/funds/creacion-ventures) — Series A